Overview of Current MicroRNA Biomarker Signatures As Potential Diagnostic Tools for Leukaemic Conditions

Overview

Journal Noncoding RNA Res

Date 2020 Feb 29

PMID 32110743

Citations 13

Authors

Alfred Buhagiar

Joseph Borg

Duncan Ayers

Affiliations

Soon will be listed here.

Abstract

Haematological malignancies encompass all variations of leukaemia at both the chronic and acute level, together with the specific cell type induced into tumourigenesis. Current diagnostic protocols for leukaemic conditions rely heavily on cytomorphology and other histological examinations from bone marrow aspirates, with the latter being a highly invasive surgical procedure for the patient. The discovery of microRNAs as one of the key gene regulatory networks in the past two decades has enabled researchers to investigate the possibility of exploiting the identification of dysregulated expression profiles for specific microRNAs present in the leukaemic patient's bloodstream as novel liquid biopsy diagnostic tools. This review article serves to consolidate recent global research efforts aiming to achieve such scopes.

Citing Articles

An overview of prognostic markers in patients with CLL.

Braish J, Cerchione C, Ferrajoli A Front Oncol. 2024; 14():1371057.

PMID: 38817892 PMC: 11137234. DOI: 10.3389/fonc.2024.1371057.

Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment.

Tahmasebi F, Asl E, Vahidinia Z, Barati S Cell Mol Neurobiol. 2024; 44(1):44.

PMID: 38713302 PMC: 11076329. DOI: 10.1007/s10571-024-01478-1.

Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.

Wang W, Wu X, Zheng J, Yin R, Li Y, Wu X Front Immunol. 2024; 14:1315453.

PMID: 38292478 PMC: 10824954. DOI: 10.3389/fimmu.2023.1315453.

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.

Sevcikova A, Fridrichova I, Nikolaieva N, Kalinkova L, Omelka R, Martiniakova M Cancers (Basel). 2023; 15(9).

PMID: 37174123 PMC: 10177548. DOI: 10.3390/cancers15092658.

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.

Mongiorgi S, De Stefano A, Ratti S, Indio V, Astolfi A, Casalin I Clin Epigenetics. 2023; 15(1):27.

PMID: 36803590 PMC: 9940408. DOI: 10.1186/s13148-023-01441-9.

References

Park N, Zhou H, Elashoff D, Henson B, Kastratovic D, Abemayor E . Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009; 15(17):5473-7. PMC: 2752355. DOI: 10.1158/1078-0432.CCR-09-0736. View

Weber J, Baxter D, Zhang S, Huang D, Huang K, Lee M . The microRNA spectrum in 12 body fluids. Clin Chem. 2010; 56(11):1733-41. PMC: 4846276. DOI: 10.1373/clinchem.2010.147405. View

Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K . Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One. 2009; 4(5):e5532. PMC: 2678255. DOI: 10.1371/journal.pone.0005532. View

Michael A, Bajracharya S, Yuen P, Zhou H, Star R, Illei G . Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2009; 16(1):34-8. PMC: 2844919. DOI: 10.1111/j.1601-0825.2009.01604.x. View

Swellam M, Hashim M, Sayed Mahmoud M, Ramadan A, Hassan N . Aberrant Expression of Some Circulating miRNAs in Childhood Acute Lymphoblastic Leukemia. Biochem Genet. 2018; 56(4):283-294. DOI: 10.1007/s10528-018-9844-y. View

Wang J, Zhang K, Liu S, Sen S . Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014; 19(2):1912-38. PMC: 6271223. DOI: 10.3390/molecules19021912. View

Inaba H, Greaves M, Mullighan C . Acute lymphoblastic leukaemia. Lancet. 2013; 381(9881):1943-55. PMC: 3816716. DOI: 10.1016/S0140-6736(12)62187-4. View

Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly M . MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A. 2007; 104(50):19971-6. PMC: 2148407. DOI: 10.1073/pnas.0709313104. View

Yan J, Wu G, Chen J, Xiong L, Chen G, Li P . Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia. Cancer Biomark. 2018; 22(1):73-78. DOI: 10.3233/CBM-170936. View

10.

Mitchell P, Parkin R, Kroh E, Fritz B, Wyman S, Pogosova-Agadjanyan E . Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105(30):10513-8. PMC: 2492472. DOI: 10.1073/pnas.0804549105. View

11.

McManus M . MicroRNAs and cancer. Semin Cancer Biol. 2003; 13(4):253-8. DOI: 10.1016/s1044-579x(03)00038-5. View

12.

Luna-Aguirre C, de la Luz Martinez-Fierro M, Mar-Aguilar F, Garza-Veloz I, Trevino-Alvarado V, Rojas-Martinez A . Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia. Cancer Biomark. 2015; 15(3):299-310. DOI: 10.3233/CBM-150465. View

13.

Fallah P, Amirizadeh N, Poopak B, Toogeh G, Arefian E, Kohram F . Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Int J Lab Hematol. 2015; 37(4):560-8. DOI: 10.1111/ijlh.12351. View

14.

Moussay E, Wang K, Cho J, Van Moer K, Pierson S, Paggetti J . MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2011; 108(16):6573-8. PMC: 3081030. DOI: 10.1073/pnas.1019557108. View

15.

Jiang Q, Lu X, Huang P, Gao C, Zhao X, Xing T . Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia. Biomed Res Int. 2018; 2018:5724686. PMC: 6008837. DOI: 10.1155/2018/5724686. View

16.

Kosaka N, Iguchi H, Ochiya T . Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010; 101(10):2087-92. PMC: 11159200. DOI: 10.1111/j.1349-7006.2010.01650.x. View

17.

Agirre X, Jimenez-Velasco A, Jose-Eneriz E, Garate L, Bandres E, Cordeu L . Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res. 2008; 6(12):1830-40. DOI: 10.1158/1541-7786.MCR-08-0167. View

18.

Zen K, Zhang C . Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012; 32(2):326-48. DOI: 10.1002/med.20215. View

19.

Jiang L, Deng T, Wang D, Xiao Y . Elevated Serum Exosomal miR-125b Level as a Potential Marker for Poor Prognosis in Intermediate-Risk Acute Myeloid Leukemia. Acta Haematol. 2018; 140(3):183-192. DOI: 10.1159/000491584. View

20.

Tian C, Zhang L, Li X, Zhang Y, Li J, Chen L . Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia. Cancer Biomark. 2018; 22(2):209-215. DOI: 10.3233/CBM-170657. View